Archer: Enabling a paradigm shift in the way clinical trials are conducted
Archer: Enabling a paradigm shift in the way clinical trials are conducted
批准号:
10004435
负责人:
金额:
$44.56万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2021
资助国家:
英国
项目状态:
已结题
起止时间:
2021 至 --
中文摘要
IgniteData是一家令人兴奋的快速发展的英国中小企业,它使用数据和技术来简化临床研究过程的关键阶段。它提供世界领先的软件和咨询服务,包括其临床试验数据管理系统“Archer”,以促进临床研究中数据的使用,确保正确的数据传输和验证,并使临床研究能够更快速和更具成本效益地进行。该项目将加速Archer的开发和商业化,IgniteData的“下一代”基于云的数字健康平台(称为“软件即服务”或SaaS)。Archer能够远程访问和转换患者医疗记录,以便快速、自动地向多个研究应用程序(包括关键的Covid-19临床研究)提供准确、跟踪和验证的数据。Archer将为医疗保健提供者和研究人员提供实时的患者水平见解。这项创新将允许将二级医疗中的非结构化和结构化数据从EHR转移到临床试验EDC平台,取代目前导致严重时间延迟,错误和额外成本的手动转录方法。
英文摘要
IgniteData is an exciting, fast-growing UK SME that uses data and technology to streamline key stages of the clinical research process. It provides world-leading software and consultancy services, including its clinical trial data management system, 'Archer', to facilitate the use of data in clinical investigations, ensure correct data transfer and validation and enable clinical studies to be carried out more quickly and cost-effectively.This project will accelerate the development and commercialisation of Archer, IgniteData's 'next-generation' cloud-based digital-health platform (termed a 'Software-as-a-Service' or SaaS). Archer is capable of remotely accessing and transforming patient medical records to enable the rapid, automated delivery of accurate, tracked and validated data to multiple research applications, including critical Covid-19 clinical research.Archer will provide real-time patient level insights to healthcare providers, and researchers. This innovation will allow the transfer of unstructured and structured data from EHRs in secondary care to clinical trial EDC platforms, replacing the manual transcription methods that currently lead to significant time delays, errors and additional costs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金